View Document Preview and Link Document Date: 2008-05-11 05:40:38 Open Document File Size: 545,40 KB Share Result on Facebook
City San Francisco / Boca Raton / Zu¨rich / Groningen / FRANKFURT/MAIN / San Antonio / Aargau / Zurich / VILLIGEN / Crouch / Frankfurt / Darmstadt / VILLIGEN-PSI / / Company Mini Instruments Ltd. / Rahn AG / Millipore Corp. / Merz & Co. / CRC Press / Hitachi / Merck / Elsevier Science Inc. / Clineschmidt B. V. / Siemens / / Country Germany / Switzerland / Netherlands / United States / United Kingdom / / Currency USD / / / Event FDA Phase / / Facility Animal Research Institute / Pike V. W. / Lodge D. / PAUL SCHERRER INSTITUTE / University of Zurich / / IndustryTerm no-carrier-added nucleophilic radiofluorination / important tools / synchronized on-line electronic acquisition / sigma recognition site / dopaminergic systems / treatment of various neurological and psychiatric disorders / food / potential tool / recognition site / extracellular solutions / mL solution / treatment of Parkinson’s disease / no-carrier / / MedicalCondition traumatic CNS injury / Huntington’s disease / injury / hypoglycemia / neurological and psychiatric disorders / Alzheimer’s disease / Cerebral Ischemia / neurological disease / reflex epilepsy / Parkinson’s disease / diseases / epilepsy / depression / / OperatingSystem Microsoft Windows / / Organization Bank of Canada / CENTRE FOR RADIOPHARMACY / Animal Research Institute / University of Zurich / EPC / J. Lab. / National Basketball Association / Paul Scherrer Institute / / Person Van Waarde / R. Scho / Lesley Allemann / Y. Eichholzer / Simon Ametamey / / Position Bliss T. V. P. / head / Schlyer D. J. / MATERIALS AND METHODS General / / Product haloperidol / Nembutal / Glycine / PET / IV injection / / ProvinceOrState Texas / Florida / / SportsEvent nba / / Technology modified protocol / tomography / pharmacokinetics / pharmacodynamics / Medical Imaging / / SocialTag 
ISSN/$PII S0969Nuclear Medicine & Biology, Vol. 25, pp. 323–330, 1998 Copyright © 1998 Elsevier Science Inc.